Discover
IART
Integra LifeSciences Holdings Corporation
17.89
2 x 13.25
2 x 23.04
bid
ask
-
0.07
0.39%
2 @ 04:00 PM
18.16 +0.27 (1.51%)
| Ytd | 44.04% | |
| 1y | 35.02% |
17.86
day range
18.52
8.70
52 week range
18.92
| Open | 18.07 | Prev Close | 17.96 | Low | 17.86 | High | 18.52 | Mkt Cap | 1.39B |
| Vol | 796.66K | Avg Vol | 1.00M | EPS | -6.47 | P/E | N/A | Forward P/E | 6.86 |
| Beta | 1.25 | Short Ratio | 7.92 | Inst. Own | 100.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 15.05 | 200-d Avg | 12.88 | 1yr Est | 17.43 |
| Income Statement | |||
| Total Revenue | 391.92M | ||
| Revenues (USD) | 391.92M | ||
| Cost of Revenue | 174.94M | ||
| Gross Profit | 216.98M | ||
| Operating Expenses | 205.51M | ||
| Research and Development Expense | 23.50M | ||
| Selling, General and Administrative Expense | 178.24M | ||
| Operating Income | 11.47M | ||
| Interest Expense | 22.47M | ||
| Income Tax Expense | 2.21M | ||
| Net Income | -4.62M | ||
| Net Income Common Stock | -4.62M | ||
| Net Income Common Stock (USD) | -4.62M | ||
| Consolidated Income | -4.62M | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | 20.06M | ||
| Earning Before Interest & Taxes (USD) | 20.06M | ||
| Weighted Average Shares | 76.95M | ||
| Weighted Average Shares Diluted | 76.95M | ||
| Balance Sheet | |||
| Cash and Equivalents | 236.81M | ||
| Cash and Equivalents (USD) | 236.81M | ||
| Investments | 28.69M | ||
| Investments Current | 28.69M | ||
| Trade and Non-Trade Receivables | 264.41M | ||
| Current Assets | 1.17B | ||
| Property, Plant & Equipment Net | 584.08M | ||
| Total Assets | 3.58B | ||
| Debt Current | 52.68M | ||
| Total Debt | 2.04B | ||
| Current Liabilities | 346.85M | ||
| Debt Non-Current | 1.99B | ||
| Total Liabilities | 2.54B | ||
| Accumulated Retained Earnings (Deficit) | 418.82M | ||
| Accumulated Other Comprehensive Income | -30.94M | ||
| Shareholders Equity | 1.04B | ||
| Shareholders Equity (USD) | 1.04B | ||
| Assets Non-Current | 2.41B | ||
| Total Debt (USD) | 2.04B | ||
| Deferred Revenue | 11.62M | ||
| Goodwill and Intangible Assets | 1.72B | ||
| Inventory | 495.04M | ||
| Liabilities Non-Current | 2.19B | ||
| Trade and Non-Trade Payables | 87.95M | ||
| Tax Assets | 68.08M | ||
| Tax Liabilities | 9.38M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 38.43M | ||
| Net Cash Flow from Financing | 8.30M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.76M | ||
| Capital Expenditure | -14.85M | ||
| Issuance (Purchase) of Equity Shares | 760.00K | ||
| Issuance (Repayment) of Debt Securities | 8.91M | ||
| Net Cash Flow from Investing | -14.85M | ||
| Net Cash Flow from Operations | 9.80M | ||
| Effect of Exchange Rate Changes on Cash | -1.49M | ||
| Share Based Compensation | 5.17M | ||